May 27, 2025
2:00 PM - 3:00 PM (your local time)
Join our webinar to explore the structure-based design of subtype-selective mGlu2 agonists with GOLD and BIOVIA Discovery Studio.
Metabotropic glutamate receptors (mGluRs) play a crucial role in modulating excitatory neurotransmission in the central nervous system (CNS), making them promising drug targets for neurological and psychiatric disorders. We applied structure-based drug design methods in BIOVIA Discovery Studio and molecular docking with GOLD to develop a highly potent and selective mGlu2 receptor agonist. We also explored the biological significance of mGlu2/mGlu3 selectivity, its impact on CNS pharmacology, and how computational tools can help predict ligand-receptor interactions.
Whether you are a medicinal chemist, computational biologist, or neuroscientist, don’t miss the opportunity to explore the impact of advanced molecular modeling in accelerating CNS-targeted drug discovery.
Webinar highlights:
Register now to reserve your space!